204 related articles for article (PubMed ID: 33107741)
1. Proteomic Profiling of the Human Tissue and Biological Fluid Proteome.
Di Meo A; Sohaei D; Batruch I; Alexandrou P; Prassas I; Diamandis EP
J Proteome Res; 2021 Jan; 20(1):444-452. PubMed ID: 33107741
[TBL] [Abstract][Full Text] [Related]
2. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
3. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
4. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
5. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Profiling of Cerebrospinal Fluid by 16-Plex TMT-Based Mass Spectrometry.
Dey KK; Sun H; Wang Z; Niu M; Wang H; Jiao Y; Sun X; Li Y; Peng J
Methods Mol Biol; 2022; 2420():21-37. PubMed ID: 34905163
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
8. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
10. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
Perrin RJ; Payton JE; Malone JP; Gilmore P; Davis AE; Xiong C; Fagan AM; Townsend RR; Holtzman DM
PLoS One; 2013; 8(5):e64314. PubMed ID: 23700471
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis and annotation of human normal urinary proteome.
Zhao M; Li M; Yang Y; Guo Z; Sun Y; Shao C; Li M; Sun W; Gao Y
Sci Rep; 2017 Jun; 7(1):3024. PubMed ID: 28596590
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sample preparation techniques and data analysis for the LC-MS/MS-based identification of proteins in human follicular fluid.
Lehmann R; Schmidt A; Pastuschek J; Müller MM; Fritzsche A; Dieterle S; Greb RR; Markert UR; Slevogt H
Am J Reprod Immunol; 2018 Aug; 80(2):e12994. PubMed ID: 29938851
[TBL] [Abstract][Full Text] [Related]
13. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
[TBL] [Abstract][Full Text] [Related]
14. A Proteomic Analysis of Individual and Gender Variations in Normal Human Urine and Cerebrospinal Fluid Using iTRAQ Quantification.
Guo Z; Zhang Y; Zou L; Wang D; Shao C; Wang Y; Sun W; Zhang L
PLoS One; 2015; 10(7):e0133270. PubMed ID: 26222143
[TBL] [Abstract][Full Text] [Related]
15. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
[TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometry-Based Assay for Targeting Fifty-Two Proteins of Brain Origin in Cerebrospinal Fluid.
Batruch I; Lim B; Soosaipillai A; Brinc D; Fiala C; Diamandis EP
J Proteome Res; 2020 Aug; 19(8):3060-3071. PubMed ID: 32315192
[TBL] [Abstract][Full Text] [Related]
17. Deep Dive on the Proteome of Human Body Fluids: A Valuable Data Resource for Biomarker Discovery.
Li Y; Xun D; Li L; Wang B; Lv J; Liu H; Zhu L; Ma F; Chen X; Tian S; Ding C
Cancer Genomics Proteomics; 2021; 18(4):549-568. PubMed ID: 34183388
[TBL] [Abstract][Full Text] [Related]
18. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
[TBL] [Abstract][Full Text] [Related]
19. Experimental Null Method to Guide the Development of Technical Procedures and to Control False-Positive Discovery in Quantitative Proteomics.
Shen X; Hu Q; Li J; Wang J; Qu J
J Proteome Res; 2015 Oct; 14(10):4147-57. PubMed ID: 26051676
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
